MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from human amniotic membrane and birth tissues and human skin and bone. Its products are primarily targeted toward the wound-care, surgical, sports medicine, and orthopedics markets. MiMedx’s key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. It also sells OrthoFlo, an allograft derived from amniotic fluid. In addition, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.